CONCORD, Mass., Aug. 28, 2023 /PRNewswire/ — Comanche Biopharma Corp., a clinical stage biopharmaceutical company developing an siRNA investigational drug for the treatment of sFlt1-mediated pre-term preeclampsia, is pleased to announce that Fierce Biotech has named it as one of its 2023…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.